Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing Revision: v3.5.3. It updates the page's revision tag to reflect a newer version of the record.
    Difference
    0.1%
    Check dated 2026-05-15T05:42:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site/version refresh rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:39:14.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:33.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    - Version history updated: added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:58:47.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Footer/revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:55:12.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:37:35.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.